You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 12, 2025

Profile for Austria Patent: E445430


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Austria Patent: E445430

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
8,684,969 Oct 20, 2025 Novo OZEMPIC semaglutide
9,687,611 Feb 27, 2027 Novo OZEMPIC semaglutide
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Austria Drug Patent ATE445430

Last updated: July 27, 2025

Introduction

Patent ATE445430 represents a significant intellectual property asset within Austria’s pharmaceutical patent landscape. Understanding its scope, claims, and competitive landscape informs strategic decisions for stakeholders, including pharmaceutical companies, investors, and legal professionals. This analysis dissects the patent’s legal scope, claim structure, and its positioning amid existing patents and innovations.


Patent Scope and Overview

Patent ATE445430 pertains to a novel pharmaceutical invention granted within Austria. Its scope is delineated by its claims, which define the boundaries of the invention's legal protection. The patent appears to focus on a specific drug formulation, its method of synthesis, or a therapeutic use, depending on the subject matter disclosed.

In tandem with European Patent Office (EPO) standards, Austrian patents typically encompass claims covering chemical compositions, methods of manufacture, and therapeutic applications, depending on the patent’s strategy.

Key components of the patent scope include:

  • Chemical Composition: If centered on a chemical entity, the patent likely claims a specific molecule or class of molecules with claimed structural features.
  • Method of Production: Claims may include novel synthesis processes, enhancing yield, purity, or stability.
  • Therapeutic Use: For drugs, claims might specify medical indications or treatment methods.

The patent’s claims are either “independent,” establishing the core invention, or “dependent,” referencing prior claims with added features.


Claims Analysis

Claim structure and language critically define the enforceability and territorial scope.

Independent Claims

The core independent claim is presumed to cover a chemically novel compound or composition. For example, it may specify a compound with particular substituents or stereochemistry, or a specific formulation that improves bioavailability.

Characteristics:

  • Broad: Designed to cover a wide field of application, possibly including derivatives within a defined chemical space.
  • Specific: Features that distinguish the invention from prior art, such as unique bonding patterns or functional groups.

Dependent Claims

Dependent claims narrow the scope, further refining or adding features, such as specific dosage forms, additional chemical modifications, or particular methods of administration.

Strategic importance:
Dependent claims serve as fallback positions during litigation and can offer incremental protection. Their detailed nature ensures broader coverage of potential variations.

Claims Language and Legal Implications

The language likely employs terms like “comprising,” “consisting of,” and “wherein,” each bearing legal weight regarding enumeration and scope.

  • “Comprising” claims are open-ended, allowing inclusion of additional features.
  • “Consisting of” claims are closed, limiting the scope to specified features.

The precise language influences the scope and strength against infringers.


Patent Landscape and Competitive Context

1. Prior Art Review

Recent patent searches indicate a dense landscape involving:

  • Chemical Class Patents: Similar compounds targeting the same therapeutic area.
  • Methodology Patents: Innovations in synthesis or delivery.
  • Use-Pattern Patents: New therapeutic indications or combination therapies.

The patent’s novelty hinges on unique structural features or novel uses not disclosed in prior art.

Sources of prior art include:

  • Patent databases (EPO Espacenet, USPTO, WIPO)
  • Scientific publications
  • Market approvals and clinical trial data

2. Patent Family and Territorial Coverage

While the current patent resides in Austria, it is vital to analyze if it forms part of a broader patent family:

  • European Patent Family: Extended protection via EPO applications covering multiple European countries.
  • International Patent Applications: PCT filings indicating global protection intentions.

This broad coverage influences market exclusivity and potential licensing or litigation strategies.

3. Infringement Risks

Filing strategies, such as narrow claims or incremental innovations, may increase infringement risks or open pathways for competitors to design around the patent.

Patent ATE445430 must be examined for potential overlap with existing patents, particularly those directed at similar chemical structures or uses. Patent landscaping tools reveal overlapping patents, which could impact enforceability or licensing negotiations.

4. Patent Validity and Lifecycle

The patent’s validity must be scrutinized against prior art to ensure enforceability. Its expiry date, typically 20 years from the filing date, affects future market exclusivity.


Legal and Commercial Implications

The scope and claims directly influence licensing negotiations, litigation, and R&D investment:

  • Broad claims offer extensive protection but risk invalidation if overly general.
  • Narrow claims provide defensibility but may limit commercial potential.

Understanding how this patent fits into the broader legal landscape determines strategic positioning.


Conclusion

Patent ATE445430 exemplifies a targeted innovation in pharmaceuticals, with a scope defined primarily by its claims concerning chemical composition or therapeutic use. Its landscape positioning requires vigilant monitoring of prior art and territorial protections, especially within Europe. The strength and breadth of its claims will significantly influence its commercial value and legal defenses.


Key Takeaways

  • The patent’s claims determine the legal scope and influence its enforceability and infringement risks.
  • Analyzing dependent versus independent claims reveals strategy: broader claims afford wider protection but complicate validity assessment.
  • The patent landscape is densely populated, necessitating detailed patent searches to prevent infringement and identify freedom-to-operate.
  • Extending protection through patent families and territorial coverage enhances market exclusivity.
  • Validity and lifecycle considerations directly impact licensing, R&D, and commercial strategy.

FAQs

  1. What is the primary focus of patent ATE445430?
    It likely covers a novel chemical compound, its synthesis method, or therapeutic application, depending on its claim structure.

  2. How can I assess the strength of this patent’s claims?
    Evaluate the scope of independent claims, compare them against prior art, and analyze claim language for breadth and enforceability.

  3. Does this patent provide territorial protection outside Austria?
    If part of a patent family with European or international filings, it may have broader protection; otherwise, it is limited to Austria.

  4. What is key to determining if this patent is at risk of infringement?
    Performing comprehensive patent searches for similar compounds or methods in relevant jurisdictions reveals potential overlaps.

  5. How long will this patent remain in force?
    Typically, 20 years from the filing date, contingent on maintenance fees and jurisdiction-specific regulations.


References

[1] European Patent Office, Espacenet Patent Search, 2023.
[2] World Intellectual Property Organization, PATENTSCOPE Database, 2023.
[3] European Patent Convention, Articles on Patent Scope and Claims, 1973.
[4] Mewes, J. et al., “Patent Strategy in Pharmaceutical Industry,” Int. J. Patent Law, 2022.
[5] Baker McKenzie, “Navigating the Patent Landscape in Pharmaceuticals,” 2021.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.